期刊
ACTA ENDOCRINOLOGICA-BUCHAREST
卷 8, 期 1, 页码 59-66出版社
EDITURA ACAD ROMANE
DOI: 10.4183/aeb.2012.59
关键词
Cholecalciferol; vitamin D3; iPTH; pregnancy; cord blood
资金
- Research Institute of Endocrine Sciences, Shahid Beheshti University of Medical Sciences
Context. Vitamin D is essential for skeletal and nonskeletal health and prolonged deficiency results in infantile rickets and adult osteomalacia. The aim of this study is to determine 25(011) VitD and iPTH status in pregnancy and to evaluate the effects of monthly 100.000 IU dose of vitamin D supplementation. Materials and Methods. In a double blind trial of vitamin D supplementation in pregnant Iranian women, vitamin D3 (cholecalciferol, 100/00 IU/month) was administered to 25 women and placebo to 25 controls during the last trimester. The two groups had similar distributions of maternal age, height, gravity, weight and age of gestation. Hydroxycholcalciferol and iPTH were measured in mothers at 27 weeks and at delivery. Cord blood was used to assess the same parameters. Results. Comparing the data final maternal 25 - hydroxyvitamin D levels were significantly higher in the supplemented group versus control group (61.45 +/- 30 ng/mL versus 29.4 +/- 16 ng/mL); P <= 0.001. Cord 25 - hydroxyvitamin D levels were significantly higher in supplementation group in comparison to control group (52 +/- 40.5 ng/mL versus 36 +/- 21.3 ng/mL); P<0.005. Conclusion. Administration of 100/000 IU/monthly of vitamin D3 in the last trimester significantly increased 25(OH) VitD to high normal concentration. However, even with supplementation, only of mother and of newborn had scrum 25(OH) VitD greater than 30 ng/mL a small percentage of women and babies were vitamin D sufficient. According to data of study we propose 100/000 IU monthly is safe for pregnant women.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据